Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance

Apolipoprotein AII (apoAII) transgenic (apoAIItg) mice exhibit several traits associated with the insulin resistance (IR) syndrome, including IR, obesity, and a marked hypertriglyceridemia. Because treatment of the apoAIItg mice with rosiglitazone ameliorated the IR and hypertriglyceridemia, we hypo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Castellani, Lawrence W., Nguyen, Cara N., Charugundla, Sarada, Weinstein, Michael M., Doan, Chau X., Blaner, William S., Wongsiriroj, Nuttaporn, Lusis, Aldons J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2008
Matèries:
Lipids and Lipoproteins: Metabolism, Regulation, and Signaling
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2431075/
https://ncbi.nlm.nih.gov/pubmed/18160395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M708995200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars